Crowdonomics
CaryRx

Reg CF · SAFE · Nov 2018

ClosedReached targetReg CFSAFE
via WeFunder · last checked Aug 17, 2026
Raised
$137.4K / $1.1M max
13% of ceiling
Investors
158
$869.7 avg
Valuation cap
$8M
cap, not an agreed valuation

Financials disclosed in this offering

FY2016–FY2017 · hover for source
$0
−$53K
FY2016
$59K
−$137K
FY2017
RevenueNet income
Metric
FY2016 reviewed*
FY2017 reviewed*
Income statement
Revenue
$0
$58,646
Cost of goods sold
$0
$57,209
Gross margin
—
2%
Net income
-$53,209
-$137,476
Taxes paid
$175
$475
Balance sheet
Cash
-$628
$15,950
Accounts receivable
$0
$0
Total assets
$66,884
$156,075
Short-term debt
$11,068
$119,224
Long-term debt
$45,676
$161,375
Total liabilities
$56,744
$280,599
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Feb 22, 2019
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Valuation cap$8M

Offering details

Target$100,000
Max$1,070,000
Min investment$250
OpenedNov 13, 2018
DeadlineApr 20, 2019
ClosedApr 20, 2019
Days active158

Links & provenance

Source: SEC EDGAR
0001670254-18-000536
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.